Hemp & CBD Policy: Ghana’s industrial hemp rollout is stuck: no licenses issued four months after launch, while high US-dollar fees (up to $45,000/ha plus extra charges) face a constitutional court challenge—raising fears of stalled investment. Campus Enforcement: Ghana’s NACOC arrested five Central University students over cannabis-infused sweets, but the chamber says stigma shouldn’t spill onto the wider industry while licensing rules remain unfinished. Clinical CBD Watch: Avecho’s phase III insomnia trial for synthetic CBD is nearing results (about 520 patients; 75mg/150mg vs placebo), with the company positioning it for an OTC pharmacy path. Industry Growth (Hempcrete): Taranaki’s hemp fibre plan flags hempcrete as the most immediate market opportunity, aiming to connect local growing, processing, and construction demand. Tech & Cannabis Manufacturing: Vape-Jet moved its cannabis automation HQ, engineering, and manufacturing to Pittsburgh’s Strip District, targeting precision dosing equipment for legal retail. Legal/Market Signals: Tilray stock is back in focus as investors weigh its shift toward broader lifestyle and consumer packaged goods alongside cannabis and hemp foods. Regulatory/Legal Risk: Wisconsin remains a no-marijuana state even if products are bought elsewhere; CBD is legal, but psychoactive hemp variants like Delta-8 raise concerns. Crime & Seizures: Police actions across multiple regions continue to feature cannabis—ranging from school-area vape THC findings to large seizures and arrests tied to trafficking networks.